US20050074469A1 - Stable lipophilic emulsions for acrylic coating and method of making - Google Patents

Stable lipophilic emulsions for acrylic coating and method of making Download PDF

Info

Publication number
US20050074469A1
US20050074469A1 US10/679,101 US67910103A US2005074469A1 US 20050074469 A1 US20050074469 A1 US 20050074469A1 US 67910103 A US67910103 A US 67910103A US 2005074469 A1 US2005074469 A1 US 2005074469A1
Authority
US
United States
Prior art keywords
emulsion
accordance
lipophile
water
stabilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/679,101
Inventor
Charles Signorino
Terry Smith
Louis Forcellini
Aaron Barkley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emerson Resources Inc
Original Assignee
Emerson Resources Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emerson Resources Inc filed Critical Emerson Resources Inc
Priority to US10/679,101 priority Critical patent/US20050074469A1/en
Assigned to EMERSON RESOURCES INC. reassignment EMERSON RESOURCES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARKLEY, AARON M., FORCELLINI, LOUIS J., SIGNORINO, CHARLES, PH.D., SMITH, TERRY L.
Publication of US20050074469A1 publication Critical patent/US20050074469A1/en
Priority to US11/163,735 priority patent/US8591920B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Definitions

  • the present invention relates to stable lipophilic emulsions. More particularly, the present invention relates to stable lipophilic emulsions which may be stored and shipped for use with polymers comprised of acrylic and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters for the coating of pharmaceutical dosage forms.
  • the coating of pharmaceutical dosage forms utilizing acrylic and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters usually required the addition of talc to prevent the coating from being sticky and causing defects by tablets sticking to each other or the coating equipment.
  • the sticking together of tablets and their separation causes deformities in the coating which are referred to in the art as “picks” when the pharmaceutical dosage forms such as tablets or capsules are separated.
  • a low solids emulsion of the lipophile such as glycerol monostearate at 2%
  • preparation of the most useful dispersions use an emulsion stabilizer at about 40% of the lipophile.
  • the emulsion stabilizer, a surface active ingredient, at this level may have an adverse effect on the permeability of the film.
  • the lipophilic emulsion since the lipophilic emulsion is not stable for periods more than several hours, the lipophilic emulsion must be prepared as a part of the process of coating the pharmaceutical dosage forms and this preparation requires heating of the ingredients, dispersing the ingredients and then cooling the dispersion before incorporation into the coating suspension. This is a cumbersome preparation process at the manufacturing and coating facility and this process of preparing the lipophilic emulsion during the coating process creates difficulties which manufacturers would like to avoid.
  • a lipophilic emulsion may be prepared at a high concentration and stabilized such that it may be stored and shipped and may be presented for use in the coating suspension at the time of coating with no heating, homogenizing or cooling.
  • a lipophile such as glycerol monostearate
  • water at high concentration and stabilized.
  • any quantity of lipophile may be delivered from a stable emulsion concentrate to facilitate coating suspension preparation.
  • lipophiles may be chosen from glycerol monostearate (GMS), glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, other glycerides including diacetylated monoglyceride and vegetable oils such as corn or coconut oils.
  • GMS glycerol monostearate
  • glycerol monooleate glycerol monolaurate
  • propylene glycol monolaurate propylene glycol monooleate
  • propylene glycol monostearate propylene glycol monostearate
  • sorbitan monooleate propylene glycol monostearate
  • sorbitan monostearate other glycerides including diacetylated monoglyceride and vegetable oils such as corn or coconut oils.
  • stable lipophilic emulsions may be prepared with emulsion stabilizer by weight of between 1% and 5% of the lipophile.
  • emulsion stabilizers which may be used include polysorbate 80 (PS 80), sodium lauryl sulfate and polysorbate 60.
  • plasticizers may be included in the emulsion.
  • the plasticizers may include triethyl citrate (TEC), triacetin (TA), glycerin, propylene glycol (PG) and polyethylene glycol (PEG 400-8000 MW).
  • the present invention comprises an emulsion wherein a lipophile is chosen from the group consisting of glycerol monostearate, glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, diacetylated monoglyceride and vegetables oils.
  • An effective amount of an emulsion stabilizer such as polysorbate 80 is used.
  • An effective amount of an emulsion stabilizer may be by weight between 1% and 5% of the lipophile.
  • the lipophile and the emulsion stabilizer are homogenized to form micelles having a size of 50 microns or less. This emulsion is stable for a period of at least three months.
  • an emulsion of a water insoluble lipophile is produced by bringing the water to a temperature of between 60 and 80 degrees centigrade, adding the lipophile, adding an emulsion stabilizer, stirring vigorously for approximately 5 minutes, passing the mixture through a homogenizer for between about 10 to 120 minutes and cooling the emulsion to room temperature while stirring.
  • the 10 to 120 minutes corresponds to 3 to 10 passes of the formulation through a homogenizer or, in other words, 3 to 10 cycles.
  • a lipophile such as glycerol monostearate
  • glycerol monostearate can be dispersed in water at high concentrations to prepare stable emulsions that can be stored and shipped for later use with emulsions of polymers comprising acrylic acid and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters for coating pharmaceutical dosage forms without having to prepare a lipophilic emulsion at the coating location.
  • Lipophiles that may be utilized in practicing the invention include, in addition to glycerol monostearate, glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, as well as other glycerides such as diacetylated monoglyceride (i.e. Myvacet 9-45, commercially available from Quest International, 5115 Sedge Boulevard, Hoffman Estates, Ill., 60192), and vegetable oils such as corn and coconut oils.
  • diacetylated monoglyceride i.e. Myvacet 9-45, commercially available from Quest International, 5115 Sedge Boulevard, Hoffman Estates, Ill., 60192
  • vegetable oils such as corn and coconut oils.
  • the stable lipophilic emulsions may be used directly with the acrylic polymers without any heating, homogenizing or cooling to form the lipophilic emulsion. Any quantity of lipophile may be delivered from a stable lipophilic emulsion concentrate to facilitate coating suspension preparation.
  • stable dispersions or emulsions of the various lipophiles may be prepared with an emulsion stabilizer such as polysorbate 80 using only an amount of the emulsion stabilizer which is 1% to 5% of the weight of the lipophile.
  • emulsion stabilizers may be used including sodium lauryl sulfate and polysorbate 60.
  • the lipophilic emulsion remains stable with the use of plasticizers in the suspension.
  • the plasticizers may include triethyl citrate (TEC), triacetin (TA), glycerin, propylene glycol (PG) and polyethylene glycol (PEG 400-8000 MW). These dispersions can be added to all of the acrylic resin copolymer dispersions.
  • Some acrylic copolymers are available as dry 100% powders, for example, Eudragit L100, commercially available from Rohm America LLC, 2 Turner Place, Piscataway, N.J. 08855. Such acrylic copolymers need to be dispersed into water before adding the lipophilic emulsion to produce the coating composition.
  • Glycerol Monostearate 10.00 kg Triethyl Citrate (TEC) 9.60 (20.00% solids) Polysorbate 80 (PS80) 0.40 Water 80.00
  • Example 1 In preparing the lipophilic emulsion of Example 1, water was charged to a 50 gallon tank and heated to 70 degrees centigrade with stirring. The triethyl citrate and polysorbate 80 were added and the temperature was raised to 70 degrees centigrade. The glycerol monostearate was sprinkled onto the surface of the water slowly allowing it to melt and to be incorporated into the suspension. The mixture was stirred vigorously with a propeller mixer. The mixture was passed through an in-line homogenizer for 15 minutes, recirculating into the stirred batch. The suspension was inspected under a microscope at 100 magnification and the emulsion contained micelles of about 10 microns. The homogenizer was turned off and the batch was cooled with stirring to 30 degrees centigrade.
  • Example 1 The homogenizer utilized in preparing Example 1 was manufactured by Silverson Machines, Inc., 355 Chestnut Street, East Longmeadow, Mass. 01028. The mixture should be passed through the in-line homogenizer for 3 to 10 cycles and it is believed that it is important to produce micelles of 50 microns or less in order to produce the stability of the emulsion desired by the invention. The 3 to 10 cycles would take from 10 to 120 minutes. The emulsion produced is stable for at least three months and this allows adequate time for packaging, storage and distribution to manufacturers and use by the manufacturer in the coating process.
  • Preservatives may be added and the lipophilic emulsion may be packaged for storage and distribution to manufacturers in the pharmaceutical industry for use in connection with acrylic coating processes.
  • the emulsion may be shipped concentrated and effectively diluted by the coater at the time of coating.
  • Example 2 The lipophilic emulsion of Example 1 may be used in various acrylic resin copolymer coatings, a specific example is illustrated in Example 2.
  • the methacrylic acid copolymer emulsion i.e. Eudragit L30D55 commercially available from Rohm America LLC
  • water were added to a container and stirred at room temperature.
  • the lipophilic emulsion of Example 1 was added with stirring and stirred for one hour.
  • This enteric coating suspension was ready for spraying in a fluid bed coater or side vented coating machine. This is a very desirable, simplified procedure for making a coating suspension using acrylic copolymers with a pre-emulsified lipophile.
  • the coating suspension may be colored if desired by stirring in a dispersion of any of the FD&C, D&C or uncertified colorants approved for use in the pharmaceutical industry. Uncertified colorants include titanium dioxide, iron oxides, other minerals and natural colors.
  • lipophilic materials may be emulsified for inclusion into acrylic coating emulsions.
  • Example 8 Another example of the use of a lipophilic emulsion in an acrylic coating emulsion is shown in Example 8.
  • This blend may be stirred for an hour and sprayed on tablets, capsules or granules in side vented pans or fluid bed columns.

Abstract

Emulsions of lipophiles such as glycerol monostearate which are compatible with acrylic copolymer emulsions are made stable by using an emulsion stabilizer such as polysorbate 80 in an amount by weight between 1% and 5% of the lipophile and homogenizing the emulsion wherein the emulsion micelles are less than 50 microns. The ability to make a stable emulsion of a lipophile is important in the coating process as it enables preparation and shipment of the lipophilic emulsion to the coater rather than the preparation of a lipophilic emulsion at the time of the coating process which involves a heating and cooling process.

Description

    BACKGROUND OF THE INVENTION
  • The present invention relates to stable lipophilic emulsions. More particularly, the present invention relates to stable lipophilic emulsions which may be stored and shipped for use with polymers comprised of acrylic and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters for the coating of pharmaceutical dosage forms.
  • In the past, the coating of pharmaceutical dosage forms utilizing acrylic and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters usually required the addition of talc to prevent the coating from being sticky and causing defects by tablets sticking to each other or the coating equipment. The sticking together of tablets and their separation causes deformities in the coating which are referred to in the art as “picks” when the pharmaceutical dosage forms such as tablets or capsules are separated.
  • More recently, in U.S. Pat. No. 5,292,522—Petereit et al. describe the usefulness of a lipophilic material to replace talc in the coating composition. Petereit et al. elaborate on this coating process in Petereit et al., “Glycerol Monostearate as a Glidant in Aqueous Film-Coating Formulations”, European Journal of Pharmaceutics and Biopharmaceutics, Volume 41, No. 4, pages 219-228 (1995). However, the coating method utilizing glycerol monostearate is difficult to practice due to the difficulty in preparing the lipophilic material for incorporation into the polymer emulsion. All of the examples disclosed by Petereit et al. disclose the preparation of a low solids emulsion of the lipophile, such as glycerol monostearate at 2%, at the time of coating. Also, preparation of the most useful dispersions use an emulsion stabilizer at about 40% of the lipophile. The emulsion stabilizer, a surface active ingredient, at this level may have an adverse effect on the permeability of the film. Further, since the lipophilic emulsion is not stable for periods more than several hours, the lipophilic emulsion must be prepared as a part of the process of coating the pharmaceutical dosage forms and this preparation requires heating of the ingredients, dispersing the ingredients and then cooling the dispersion before incorporation into the coating suspension. This is a cumbersome preparation process at the manufacturing and coating facility and this process of preparing the lipophilic emulsion during the coating process creates difficulties which manufacturers would like to avoid.
  • SUMMARY OF THE INVENTION
  • In accordance with the present invention, a lipophilic emulsion may be prepared at a high concentration and stabilized such that it may be stored and shipped and may be presented for use in the coating suspension at the time of coating with no heating, homogenizing or cooling.
  • In accordance with the present invention, a lipophile, such as glycerol monostearate, may be dispersed in water at high concentration and stabilized.
  • In accordance with the present invention, any quantity of lipophile may be delivered from a stable emulsion concentrate to facilitate coating suspension preparation.
  • In accordance with the present invention, lipophiles may be chosen from glycerol monostearate (GMS), glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, other glycerides including diacetylated monoglyceride and vegetable oils such as corn or coconut oils.
  • In accordance with the present invention, stable lipophilic emulsions may be prepared with emulsion stabilizer by weight of between 1% and 5% of the lipophile.
  • In accordance with the present invention, emulsion stabilizers which may be used include polysorbate 80 (PS 80), sodium lauryl sulfate and polysorbate 60.
  • In accordance with the present invention, plasticizers may be included in the emulsion. The plasticizers may include triethyl citrate (TEC), triacetin (TA), glycerin, propylene glycol (PG) and polyethylene glycol (PEG 400-8000 MW).
  • Briefly and basically, the present invention comprises an emulsion wherein a lipophile is chosen from the group consisting of glycerol monostearate, glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, diacetylated monoglyceride and vegetables oils. An effective amount of an emulsion stabilizer such as polysorbate 80 is used. An effective amount of an emulsion stabilizer may be by weight between 1% and 5% of the lipophile. The lipophile and the emulsion stabilizer are homogenized to form micelles having a size of 50 microns or less. This emulsion is stable for a period of at least three months.
  • Briefly, in accordance with the method of the present invention, an emulsion of a water insoluble lipophile is produced by bringing the water to a temperature of between 60 and 80 degrees centigrade, adding the lipophile, adding an emulsion stabilizer, stirring vigorously for approximately 5 minutes, passing the mixture through a homogenizer for between about 10 to 120 minutes and cooling the emulsion to room temperature while stirring. The 10 to 120 minutes corresponds to 3 to 10 passes of the formulation through a homogenizer or, in other words, 3 to 10 cycles.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • In accordance with the present invention, a lipophile such as glycerol monostearate, can be dispersed in water at high concentrations to prepare stable emulsions that can be stored and shipped for later use with emulsions of polymers comprising acrylic acid and methacrylic acid, their alkyl esters and their alkyl amino alkyl esters for coating pharmaceutical dosage forms without having to prepare a lipophilic emulsion at the coating location.
  • Lipophiles that may be utilized in practicing the invention include, in addition to glycerol monostearate, glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, as well as other glycerides such as diacetylated monoglyceride (i.e. Myvacet 9-45, commercially available from Quest International, 5115 Sedge Boulevard, Hoffman Estates, Ill., 60192), and vegetable oils such as corn and coconut oils. The stable lipophilic emulsions may be used directly with the acrylic polymers without any heating, homogenizing or cooling to form the lipophilic emulsion. Any quantity of lipophile may be delivered from a stable lipophilic emulsion concentrate to facilitate coating suspension preparation.
  • In accordance with the present invention, stable dispersions or emulsions of the various lipophiles may be prepared with an emulsion stabilizer such as polysorbate 80 using only an amount of the emulsion stabilizer which is 1% to 5% of the weight of the lipophile. Other emulsion stabilizers may be used including sodium lauryl sulfate and polysorbate 60.
  • In accordance with the present invention, the lipophilic emulsion remains stable with the use of plasticizers in the suspension. The plasticizers may include triethyl citrate (TEC), triacetin (TA), glycerin, propylene glycol (PG) and polyethylene glycol (PEG 400-8000 MW). These dispersions can be added to all of the acrylic resin copolymer dispersions. Some acrylic copolymers are available as dry 100% powders, for example, Eudragit L100, commercially available from Rohm America LLC, 2 Turner Place, Piscataway, N.J. 08855. Such acrylic copolymers need to be dispersed into water before adding the lipophilic emulsion to produce the coating composition.
  • The following is an example of a lipophilic emulsion in accordance with the present invention.
  • EXAMPLE 1
  • MATERIAL QUANTITY
    Glycerol Monostearate (GMS) 10.00 kg
    Triethyl Citrate (TEC)  9.60 (20.00% solids)
    Polysorbate 80 (PS80)  0.40
    Water 80.00
  • In preparing the lipophilic emulsion of Example 1, water was charged to a 50 gallon tank and heated to 70 degrees centigrade with stirring. The triethyl citrate and polysorbate 80 were added and the temperature was raised to 70 degrees centigrade. The glycerol monostearate was sprinkled onto the surface of the water slowly allowing it to melt and to be incorporated into the suspension. The mixture was stirred vigorously with a propeller mixer. The mixture was passed through an in-line homogenizer for 15 minutes, recirculating into the stirred batch. The suspension was inspected under a microscope at 100 magnification and the emulsion contained micelles of about 10 microns. The homogenizer was turned off and the batch was cooled with stirring to 30 degrees centigrade.
  • The homogenizer utilized in preparing Example 1 was manufactured by Silverson Machines, Inc., 355 Chestnut Street, East Longmeadow, Mass. 01028. The mixture should be passed through the in-line homogenizer for 3 to 10 cycles and it is believed that it is important to produce micelles of 50 microns or less in order to produce the stability of the emulsion desired by the invention. The 3 to 10 cycles would take from 10 to 120 minutes. The emulsion produced is stable for at least three months and this allows adequate time for packaging, storage and distribution to manufacturers and use by the manufacturer in the coating process.
  • Preservatives may be added and the lipophilic emulsion may be packaged for storage and distribution to manufacturers in the pharmaceutical industry for use in connection with acrylic coating processes. The emulsion may be shipped concentrated and effectively diluted by the coater at the time of coating.
  • The lipophilic emulsion of Example 1 may be used in various acrylic resin copolymer coatings, a specific example is illustrated in Example 2.
  • EXAMPLE 2
  • MATERIAL QUANTITY
    USP/NF methacrylic acid copolymer (30%) 60 parts
    Lipophilic emulsion of Example 1 10 (20% solids)
    Water 30
  • The methacrylic acid copolymer emulsion (i.e. Eudragit L30D55 commercially available from Rohm America LLC) and water were added to a container and stirred at room temperature. The lipophilic emulsion of Example 1 was added with stirring and stirred for one hour. This enteric coating suspension was ready for spraying in a fluid bed coater or side vented coating machine. This is a very desirable, simplified procedure for making a coating suspension using acrylic copolymers with a pre-emulsified lipophile. The coating suspension may be colored if desired by stirring in a dispersion of any of the FD&C, D&C or uncertified colorants approved for use in the pharmaceutical industry. Uncertified colorants include titanium dioxide, iron oxides, other minerals and natural colors.
  • Additional examples of stable lipophilic emulsions are as follows.
  • EXAMPLE 3
  • MATERIAL QUANTITY
    GMS 15.0 kg
    TEC  9.8 (25% solids)
    PS80  0.2
    Water 75.0
  • EXAMPLE 4
  • MATERIAL QUANTITY
    GMS 19.8
    PS80  0.2 (20% solids)
    Water 80.0
  • EXAMPLE 5
  • MATERIAL QUANTITY
    Glycerol Monooleate 10.0
    TEC  9.8
    PS80  0.2 (20% solids)
    Water 80.0
  • EXAMPLE 6
  • MATERIAL QUANTITY
    Sorbitan Monostearate 10.0
    PEG 400  9.8
    PS80  0.2 (20% solids)
    Water 80.0
  • EXAMPLE 7
  • MATERIAL QUANTITY
    GMS 10.0
    TEC  9.9
    PS80  0.1 (20% solids)
    Water 80.0
  • In accordance with the present invention, a wide variety of lipophilic materials may be emulsified for inclusion into acrylic coating emulsions.
  • Another example of the use of a lipophilic emulsion in an acrylic coating emulsion is shown in Example 8.
  • EXAMPLE 8
  • MATERIAL QUANTITY
    Ammonium methacrylate copolymer (30%) 60.0
    Lipophilic emulsion of Example 7  6.0 (21.2% solids)
    TEC  2.0
    Water 32.0
  • This blend may be stirred for an hour and sprayed on tablets, capsules or granules in side vented pans or fluid bed columns.
  • The present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof and, accordingly, reference should be made to the appended claims, rather than to the foregoing specification as indicating the scope of the invention.

Claims (21)

1. An emulsion, comprising:
a lipophile chosen from the group consisting of glycerol monostearate, glycerol monooleate, glycerol monolaurate, propylene glycol monolaurate, propylene glycol monooleate, propylene glycol monostearate, sorbitan monooleate, sorbitan monostearate, diacetylated monoglyceride and vegetable oils;
an effective amount of an emulsion stabilizer; and
wherein said lipophiles and emulsion stabilizer are homogenized in water to form micelles having a size of 50 microns or less.
2. An emulsion in accordance with claim 1 wherein said emulsion stabilizer is selected from the group consisting of polysorbate 80, sodium lauryl sulfate and polysorbate 60.
3. An emulsion in accordance with claim 1 wherein said effective amount of an emulsion stabilizer is by weight between 1% and 5% of the lipophile.
4. An emulsion in accordance with claim 1 which includes a plasticizer.
5. An emulsion in accordance with claim 4 wherein the plasticizer is selected from the group consisting of triethyl citrate, triacetin, glycerin, propylene glycol and polyethylene glycol.
6. An emulsion in accordance with claim 1 wherein said emulsion is stable for a period of at least three months.
7. An emulsion in accordance with claim 6 wherein said emulsion is compatible with an emulsion of copolymers of acrylic and methacrylic acids and their alkyl esters and alkyl amino alkyl esters.
8. An emulsion in accordance with claim 1 wherein said emulsion stabilizer is polysorbate 80 at about 0.2% and a lipophile is glycerol monostearate at about 10% and wherein triethyl citrate at about 9.8% is used as a plasticizer, the remainder being water.
9. An emulsion in accordance with claim 1 wherein said effective amount of an emulsion stabilizer is by weight about 2% of the lipophile.
10. An emulsion in accordance with claim 1 wherein said emulsion stabilizer is polysorbate 80 at about 0.2% and the lipophile is glycerol monooleate about 19.8% and the remainder is water.
11. An emulsion in accordance with claim 1 wherein said emulsion stabilizer is polysorbate 80 at about 0.3% and the lipophile is glycerol monostearate at about 10% and further including triethyl citrate as a plasticizer at about 9.7% with the remainder being water.
12. An emulsion in accordance with claim 1 wherein said emulsion stabilizer is polysorbate 80 at about 0.1% and the lipophile is glycerol monostearate at about 10% and further including triethyl citrate at about 9.9% as a plasticizer, with the remainder being water.
13. An emulsion in accordance with claim 1 wherein the emulsion stabilizer is polysorbate 80 at about 0.2% and the lipophile is glycerol monostearate at about 10%, and further including polyethylene glycol 8000 at about 9.8% as a plasticizer, with the remainder being water.
14. An emulsion in accordance with claim 1 wherein the lipophile is 5% to 20% by weight.
15. An emulsion in accordance with claim 4 wherein the plasticizer is up to 20% of the formulation.
16. An emulsion in accordance with claim 1 wherein the emulsion stabilizer is about 0.1% to 2% of the formulation.
17. An emulsion in accordance with claim 1 which is adaptable to be stirred into an acrylic copolymer emulsion to form a stable coating suspension with a lipophile to resin ratio of between 1:10 and 1:50 for coating in side vented pans and fluid bed columns onto powders, granules, tablets or capsules.
18. An emulsion in accordance with claim 1 which is adapted to be stirred into an acrylic copolymer emulsion containing colorants at 10% to 50% of the resin content of the formulation.
19. An emulsion of a water insoluble lipophile produced by:
heating the water to a temperature of between 60 and 80 degrees centigrade;
adding a lipophile to the water while stirring;
adding an emulsifying agent;
stirring vigorously for approximately five minutes;
passing the mixture through a homogenizer for between about 10 to about 120 minutes;
cooling the emulsion to room temperature while stirring;
wherein said emulsion is stable for a period of at least three months.
20. A method in accordance with claim 19 wherein said step of passing the mixture through a homogenizer for between about 10 to about 120 minutes comprises passing the mixture through the homogenizer for between 3 and 10 cycles.
21. A method in accordance with claim 19 wherein said step of passing the mixture through a homogenizer for between about 10 to about 120 minutes is carried out to produce micelles of less than 50 microns.
US10/679,101 2003-10-03 2003-10-03 Stable lipophilic emulsions for acrylic coating and method of making Abandoned US20050074469A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/679,101 US20050074469A1 (en) 2003-10-03 2003-10-03 Stable lipophilic emulsions for acrylic coating and method of making
US11/163,735 US8591920B2 (en) 2003-10-03 2005-10-28 Stable lipophilic emulsions for acrylic coating and method of making

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/679,101 US20050074469A1 (en) 2003-10-03 2003-10-03 Stable lipophilic emulsions for acrylic coating and method of making

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/163,735 Continuation US8591920B2 (en) 2003-10-03 2005-10-28 Stable lipophilic emulsions for acrylic coating and method of making

Publications (1)

Publication Number Publication Date
US20050074469A1 true US20050074469A1 (en) 2005-04-07

Family

ID=34394097

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/679,101 Abandoned US20050074469A1 (en) 2003-10-03 2003-10-03 Stable lipophilic emulsions for acrylic coating and method of making
US11/163,735 Expired - Fee Related US8591920B2 (en) 2003-10-03 2005-10-28 Stable lipophilic emulsions for acrylic coating and method of making

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/163,735 Expired - Fee Related US8591920B2 (en) 2003-10-03 2005-10-28 Stable lipophilic emulsions for acrylic coating and method of making

Country Status (1)

Country Link
US (2) US20050074469A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
US20010026805A1 (en) * 1995-09-23 2001-10-04 Smithkline Beecham Plc Novel process

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5232370B2 (en) * 1972-08-09 1977-08-20
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4436738A (en) * 1982-03-15 1984-03-13 Mead Johnson & Company Stabilized estradiol cream composition
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
EP0706764B1 (en) * 1994-10-10 2001-07-25 The Procter & Gamble Company Beverage supply system
HU215966B (en) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Oral multiple emulsion-preconcentrate containing cyclosporin
CA2283780A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
KR20010006480A (en) * 1997-04-18 2001-01-26 우에하라 아끼라 Microemulsion
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
AU2003211146B2 (en) * 2002-02-21 2007-07-19 Valeant International (Barbados) Srl Controlled release dosage forms
EP2368445A1 (en) * 2002-06-18 2011-09-28 Martek Biosciences Corporation Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
US20010026805A1 (en) * 1995-09-23 2001-10-04 Smithkline Beecham Plc Novel process
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection

Also Published As

Publication number Publication date
US20060057167A1 (en) 2006-03-16
US8591920B2 (en) 2013-11-26

Similar Documents

Publication Publication Date Title
EP2429505B1 (en) Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
US7709025B2 (en) Enteric coatings for orally ingestible substrates
US9233074B2 (en) Delayed release film coatings containing calcium silicate and substrates coated therewith
JP7198205B2 (en) Enteric coated hard capsule
US8388983B2 (en) Film coatings containing fine particle size detackifiers and substrates coated therewith
CN105916598B (en) Immediate release film coatings containing medium chain glycerides and substrates coated therewith
US8591920B2 (en) Stable lipophilic emulsions for acrylic coating and method of making
WO2006111981A2 (en) Film coating compositions and methods providing moisture barrier
CN107847451A (en) Stable dialkyl fumarate composition
JP2960482B2 (en) Film-forming aqueous coating for solid pharmaceutical forms, process for producing the same and method for coating pharmaceutical forms
DE60207042T2 (en) PROCESS FOR PREPARING AN AQUEOUS CELLULOSE DERIVATE DISPERSION
Bühler Kollicoat grades
US10758489B2 (en) Acidifying coatings and disintegration-resistant substrates coated therewith
US20080033059A1 (en) Enteric Coating Compositions
CN105419206B (en) Powdered or granular composition comprising copolymer, dicarboxylic acids and aliphatic mono-carboxylic acids
CN104997753A (en) Cyclosporine soft capsule for immunosuppression and preparation method of cyclosporine soft capsule

Legal Events

Date Code Title Description
AS Assignment

Owner name: EMERSON RESOURCES INC., PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIGNORINO, CHARLES, PH.D.;SMITH, TERRY L.;FORCELLINI, LOUIS J.;AND OTHERS;REEL/FRAME:014581/0772

Effective date: 20031002

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION